Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
AdipoGenix is a Boston-based biopharmaceutical company developing pharmaceuticals that target human fat tissue to treat obesity and its co-morbidities, including diabetes and cardiovascular disease. Through its proprietary human fat cell-based technology, AdipoGenix identifies nontoxic, small molecule compounds that reduce the fat content in human fat tissue, which is expected to provide therapeutic benefit for these important diseases. ( www.adipogenix.com )
AdipoGenix , Inc.
801 Albany Street Suite 112
Boston, Massachusetts 02118
USA
Tel: (617) 638-5661